Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid leukemia (CML). A meta-analysis was conducted to develop a reliable prognostic scoring system for estimation of survival of patients with CML treated with interferon alfa.
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committe for the Collaborative CML prognostic factor project groups / Hasford, J; Pfirrmann, M; Hehlmann, R; Alimena, Giuliana. - In: JOURNAL OF THE NATIONAL CANCER INSTITUTE. - ISSN 0027-8874. - 90:(1998), pp. 850-858. [10.1093/jnci/90.11.850]
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committe for the Collaborative CML prognostic factor project groups
ALIMENA, Giuliana
1998
Abstract
Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid leukemia (CML). A meta-analysis was conducted to develop a reliable prognostic scoring system for estimation of survival of patients with CML treated with interferon alfa.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
